XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statement of Redeemable Noncontrolling Interest and Equity (Unaudited) - USD ($)
$ in Millions
Total
Total Thermo Fisher Scientific Inc. Shareholders’ Equity
Common Stock, $1.00 par value
Capital in Excess of Par Value
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Items
Noncontrolling Interests
Beginning Balance at Dec. 31, 2022 $ 116              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 8              
Other comprehensive income/(loss) (4)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jul. 01, 2023 113              
Balance (in shares) at Dec. 31, 2022     441,000,000          
Beginning Balance at Dec. 31, 2022 44,032 $ 43,978 $ 441 $ 16,743 $ 41,910 $ (12,017) $ (3,099) $ 54
Treasury stock beginning balance (in shares) at Dec. 31, 2022           50,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans 99 99   137   $ (38)    
Stock-based compensation 150 150   150        
Purchases of company common stock (in shares)           5,000,000    
Purchases of company common stock (3,000) (3,000)       $ (3,000)    
Dividends declared (271) (271)     (271)      
Net income/(loss) 2,646 2,650     2,650     (4)
Other comprehensive items 175 175         175  
Excise tax from stock repurchases (29) (29)       $ (29)    
Balance (in shares) at Jul. 01, 2023     441,000,000          
Treasury stock ending balance (in shares) at Jul. 01, 2023           55,000,000    
Ending Balance at Jul. 01, 2023 43,802 43,752 $ 441 17,030 44,289 $ (15,084) (2,924) 50
Beginning Balance at Apr. 01, 2023 123              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 4              
Other comprehensive income/(loss) (7)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jul. 01, 2023 113              
Balance (in shares) at Apr. 01, 2023     441,000,000          
Beginning Balance at Apr. 01, 2023 42,310 42,257 $ 441 16,889 43,064 $ (15,083) (3,054) 53
Treasury stock beginning balance (in shares) at Apr. 01, 2023           55,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans 65 65   67   $ (2)    
Stock-based compensation 74 74   74        
Dividends declared (136) (136)     (136)      
Net income/(loss) 1,358 1,361     1,361     (3)
Other comprehensive items 130 130         130  
Excise tax from stock repurchases 1 1       $ 1    
Balance (in shares) at Jul. 01, 2023     441,000,000          
Treasury stock ending balance (in shares) at Jul. 01, 2023           55,000,000    
Ending Balance at Jul. 01, 2023 43,802 43,752 $ 441 17,030 44,289 $ (15,084) (2,924) 50
Beginning Balance at Dec. 31, 2023 118              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 10              
Other comprehensive income/(loss) (6)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jun. 29, 2024 115              
Balance (in shares) at Dec. 31, 2023     442,000,000          
Beginning Balance at Dec. 31, 2023 $ 46,724 46,735 $ 442 17,286 47,364 $ (15,133) (3,224) (11)
Treasury stock beginning balance (in shares) at Dec. 31, 2023 55,541,290         56,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (in shares)     1,000,000          
Issuance of shares under stock plans $ 184 184 $ 1 209   $ (26)    
Stock-based compensation 154 154   154        
Purchases of company common stock (in shares)           6,000,000    
Purchases of company common stock (3,000) (3,000)       $ (3,000)    
Dividends declared (298) (298)     (298)      
Net income/(loss) 2,874 2,875     2,875     (1)
Other comprehensive items 811 811         811  
Contributions from (distributions to) noncontrolling interests (1)             (1)
Excise tax from stock repurchases $ (28) (28)       $ (28)    
Balance (in shares) at Jun. 29, 2024     443,000,000          
Treasury stock ending balance (in shares) at Jun. 29, 2024 61,110,092         61,000,000    
Ending Balance at Jun. 29, 2024 $ 47,419 47,432 $ 443 17,649 49,940 $ (18,187) (2,413) (12)
Beginning Balance at Mar. 30, 2024 119              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 6              
Other comprehensive income/(loss) (3)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jun. 29, 2024 115              
Balance (in shares) at Mar. 30, 2024     443,000,000          
Beginning Balance at Mar. 30, 2024 45,504 45,516 $ 443 17,482 48,542 $ (18,186) (2,764) (12)
Treasury stock beginning balance (in shares) at Mar. 30, 2024           61,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans 81 81   83   $ (2)    
Stock-based compensation 84 84   84        
Dividends declared (149) (149)     (149)      
Net income/(loss) 1,548 1,548     1,548      
Other comprehensive items 351 351         351  
Excise tax from stock repurchases $ 1 1       $ 1    
Balance (in shares) at Jun. 29, 2024     443,000,000          
Treasury stock ending balance (in shares) at Jun. 29, 2024 61,110,092         61,000,000    
Ending Balance at Jun. 29, 2024 $ 47,419 $ 47,432 $ 443 $ 17,649 $ 49,940 $ (18,187) $ (2,413) $ (12)